Skip to main navigation Skip to search Skip to main content

Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial

  • Richard F. Schlenk
  • , Pau Montesinos
  • , Hee Je Kim
  • , Antonio Romero-Aguilar
  • , Radovan Vrhovac
  • , Elżbieta Patkowska
  • , Pavel Žák
  • , Po Nan Wang
  • , James Hanyok
  • , Li Liu
  • , Yasser Mostafa Kamel
  • , Karima Imadalou
  • , Arnaud Lesegretain
  • , Jorge Cortes
  • , Mikkael A. Sekeres
  • , Hervé Dombret
  • , Sergio Amadori
  • , Jianxiang Wang
  • , Alexander E. Perl
  • , Mark J. Levis
  • Harry P. Erba
  • German Cancer Research Center
  • Heidelberg University 
  • Hospital Universitario La Fe
  • Hospital Universitario Virgen de las Nieves
  • University of Zagreb
  • Institute of Hematology and Blood Transfusion
  • Charles University
  • Chang Gung Medical Foundation
  • Daiichi Sankyo Company, Limited
  • Augusta University
  • University of Miami
  • Université Paris Cité
  • University of Rome Tor Vergata
  • Chinese Academy of Medical Sciences
  • University of Pennsylvania
  • Johns Hopkins University
  • Duke University

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Immunology and Microbiology